#askU2 -Are you aware your @RED/@ONECampaign sponsor's big pharma conflict of interest probably got @gatesfoundation out of India?
"NEW DELHI: The Centre has shut the gate on a critical national health mission, and possible conflict of interest issues arising from the foundation's 'ties' with pharmaceutical companies is one of the reasons.
All financial ties with the country's apex immunisation advisory body, National Technical Advisory Group on Immunisation (NTAGI), with the Gates Foundation have been cut off." - "Center shuts health mission gate on Bill & Melinda Gates Foundation" -The Economic Times
India is from whence Bill Gates goes on and on about polio vaccination. What they don't tell you is they went about this the 'Third World' way, using an oral polio vaccine. Oral vaccines are not used in the 'First World'. There are whole sections in books as to why. Yes it's been done, and it caused a whole hypothesis as to the biggest medical mistake that might have ever been made in all of human history. Another thing they don't tell you:
"NEW DELHI: India’s health ministry, celebrating a year of freedom from wild polio, now faces a dilemma that public health experts had predicted years ago: the very vaccine it is using to fight polio is causing more polio paralysis than the wild poliovirus. "Flip side of India’s polio success story" -The Telegraph
"Furthermore, while India has been polio-free for a year, there has been a huge increase in non-polio acute flaccid paralysis (NPAFP). In 2011, there were an extra 47,500 new cases of NPAFP. Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received." -"Polio Programme: Let us declare victory and move on." - NCBI
"In plain language, BMGF promises to assist Big Pharma in its efforts to circumvent Western regulatory regimes by sponsoring cut-rate drug trials in the periphery.
The instruments of this assistance are Gates-controlled institutions like the GAVI Alliance, the Global Health Innovative Technology Fund, and the Program for Appropriate Technology in Health (PATH) – public-private partnerships purportedly devoted to saving Third World lives. Notionally independent but so heavily funded by Gates as to function as virtual arms of the Foundation, these organizations began to conduct large-scale clinical trials in Africa and South Asia in the mid-2000s.45
Africa soon experienced an “unprecedented increase in health research involving humans” who were typically “poverty-stricken and poorly educated”46; the results were predictably lethal. In 2010 the Gates Foundation funded a Phase III trial of a malaria vaccine developed by GlaxoSmithKline (GSK), administering the experimental treatment to thousands of infants across seven African countries. Eager to secure the WHO approval necessary to license the vaccine for global distribution, GSK and BMGF declared the trials a smashing success, and the popular press uncritically reproduced the publicity.47 Few bothered to look closely at the study's fine print, which revealed that the trials resulted in 151 deaths and caused “serious adverse effects” (e.g., paralysis, seizures, febrile convulsions) in 1048 of 5949 children aged 5-17 months.48 Similar stories emerged in the wake of the Gates-funded MenAfriVac campaign in Chad, where unconfirmed reports alleged that 50 of 500 children forcibly vaccinated for meningitis later developed paralysis.49 Citing additional abuses, a South African newspaper declared: “We are guinea pigs for the drugmakers.”50
It was in India, however, that the implications of BMGF’s collaboration with Big Pharma first rose to widespread public attention. In 2010 seven adolescent tribal girls in Gujarat and Andhra Pradesh died after receiving injections of HPV (Human Papilloma Virus) vaccines as part of a large-scale “demonstrational study” funded by the Gates Foundation and administered by PATH.51The vaccines, developed by GSK and Merck, were given to approximately 23,000 girls between 10 and 14 years of age, ostensibly to guard against cervical cancers they might develop in old age.
Extrapolating from trial data, Indian physicians later estimated that at least 1,200 girls experienced severe side effects or developed auto-immune disorders as a result of the injections.52 No follow-up examinations or medical care were offered to the victims. Further investigations revealed pervasive violations of ethical norms: vulnerable village girls were virtually press-ganged into the trials, their parents bullied into signing consent forms they could not read by PATH representatives who made false claims about the safety and efficacy of the drugs. In many cases signatures were simply forged.53
An Indian Parliamentary Committee determined that the Gates-funded vaccine campaign was in fact a large-scale clinical trial conducted on behalf of the pharmaceutical firms and disguised as an “observational study” in order to outflank statutory requirements.54 The Committee found that PATH had “violated all laws and regulations laid down for clinical trials by the government” in a “clear-cut violation of human rights and a case of child abuse.”55 The Gates Foundation did not trouble to respond to the findings but issued an annual letter calling for still more health-related R&D in poor countries and reaffirming its belief in “the value of every human life.”56"
"Other dangerous drugs that failed to gain a toehold in Western markets have received similar attention from the Gates Foundation. Norplant, a subcutaneous contraceptive implant that effectively sterilizes women for as long as five years, was pulled from the US market after 36,000 women filed suit over severe side effects undisclosed by the manufacturer, including excessive menstrual bleeding, headaches, nausea, dizziness and depression.68 Slightly modified and rebranded as Jadelle, the same drug is now being heavily promoted in Africa by USAID, the Gates Foundation, and its affiliates. A recent article on the Gates-sponsored website Impatient Optimists elides its dangers and disingenuously states that the drug “never gained traction” in the US because inserting and removing the device was “cumbersome.” With Gates Foundation support, however, Jadelle “has played a pivotal role in bringing implants to the developing world” and is soon to be complemented by a second Norplant clone, Merck’s Implanon.69
An equally risky contraceptive, Pfizer’s Depo-Provera, recently received the Gates Foundation imprimatur for distribution to poor women worldwide. In the US and India feminists fought against approval of the injectable drug for decades due to its alarming list of side effects, including “infertility, irregular bleeding, decreased libido, depression, high blood pressure, excessive weight gain, breast tenderness, vaginal infections, hair loss, stomach pains, blurred vision, joint pain, growth of facial hair, acne, cramps, diarrhea, skin rash, tiredness, and swelling of limbs”70 as well as potentially irreversible osteoporosis.71
After the US Food and Drug Administration succumbed to industry pressure and granted approval in 1992, studies found a marked racial disparity in Depo-Provera prescriptions between white and African American women, leading to charges that “this form of long-acting provider-controlled birth control is routinely given to women of color in order to deny them the ability to control their own reproduction.”72 White American and European women, by contrast, receive the drug only rarely and typically as a treatment for endometriosis, greatly limiting its commercial potential in the West.
Hence Pfizer stands to benefit enormously from a Gates-sponsored program, announced with much fanfare at the 2012 London Summit on Family Planning, to distribute the drug to millions of women in South Asia and sub-Saharan Africa by 2016:73
[Y]ou do the numbers: If 120 million new women users chose Depo-Provera, at an estimated average cost between $120-$300 per woman annually, that works out to $15 billion to $36 billion in new sales annually, a nice payoff from leveraging $4 billion in research money.74
Foundation publicity suggests that its aggressive backing of a discredited drug is merely a response to appeals from poor women. “Many [African] women want to use injectable contraceptives but simply cannot get access to them,” claimed PATH President and CEO Steve Davis.75 Reproductive rights activist Kwame Fasu disagrees: “No African woman would agree to being injected if she had full knowledge of the contraceptives’ dangerous side effects.”76"
Source: "Gates and Big Pharma" -Economy of India
Gates Foundation accused of 'dangerously skewing' aid priorities by promoting 'corporate globalisation' - The Independent
No Such Thing as a Free Gift: The Gates Foundation and the Price of Philanthropy - Hudson Institute (Book)